Xcout IntelPluto Biosciences, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Pluto Biosciences, Inc. among biotechnology companies — ranked by similarity to what Pluto Biosciences, Inc. actually does, not by market-cap band.
Subscribe to see Pluto Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pluto Biosciences, Inc.
Pluto Biosciences, Inc. is a biotechnology company headquartered in Denver, Colorado, that offers a multi-omics platform for translational scientific discovery.
Pluto Biosciences, Inc. at a glance
Pluto Biosciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $7.7M across the 3 funding rounds on record. Its most recent funding round raised $3M in April 2025. Xcout tracks 11 named people at Pluto Biosciences, Inc., including Rani K. Powers (CEO).
Pluto Biosciences, Inc. leadership
- Rani K. PowersCEO
- Mark SwendsenChief Revenue Officer
- Donald E. IngberFounding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Translational Medicine Pioneer
- Irene MorgansternDirector of Preclinical Initiatives, Neuroscientist
- Rani K. PowersExecutive Officer
- Christopher GlodeDirector
5 more named people on record for Pluto Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Pluto Biosciences, Inc. funding rounds
At least $7.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $3.7M | — | |
| Seed | $1M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Pluto Biosciences, Inc. competitors
Ranked by semantic similarity — how close each company is to Pluto Biosciences, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Nautilus Biotechnology, Inc. is a development stage life sciences company focused on creating a platform technology designed to quantify and unlock the complexity of the proteome.
Biotech
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
Similar biotechnology company
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Biotech
Origin Bio operates a tissue-first data and model platform that maps cancer biology using patient tumor samples. The company generates spatial, molecular, and functional maps from real tumor tissue to support target discovery, drug response prediction, and multimodal AI modeling for researchers and life sciences partners.
Similar biotechnology company
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Biotech
Volastra Therapeutics, Inc. is a U.S. biotechnology company developing cancer medicines designed to prevent or treat metastasis, the spread of tumors to other parts of the body. It uses functional genomics and related technologies to discover therapeutic targets and serves the oncology and biopharmaceutical markets.
Healthcare
OneThree Biotech, Inc. is a New York City-based biotechnology company founded in 2018. The company develops an artificial intelligence-driven discovery platform designed to accelerate drug discovery and development by predicting novel targets, identifying patient-specific biomarkers, and finding drug candidates for repurposing.
Healthcare
Eclipsebio is a biotechnology company headquartered in San Diego, California, that provides specialized RNA biology expertise and proprietary analytical technologies. It offers research and development services to help drug developers make informed decisions regarding RNA therapeutics.
Similar biotechnology company
Plato BioPharma, Inc. is a life sciences company headquartered in Westminster, Colorado, that offers expert preclinical drug discovery and pharmacological research services.
Similar biotechnology company
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Similar biotechnology company
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Similar biotechnology company
Transcripta Bio is a biotechnology company headquartered in Palo Alto, California, that maps cellular responses to diseases to discover and identify therapeutic molecules.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pluto Biosciences, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pluto Biosciences, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →